Sep 20, 2020, 08:43PM ISTSource: ANI
Council of Scientific and Industrial Research on September 20 informed that Drugs Controller General of India has approved CSIR’s paper-based testing kit called Feluda for COVID-19. CSIR, Director General S Mande said, “Our Delhi CSIR lab’s been working on studying CRISPR-Cas immunity. They have experience of working in this particular area before COVID-19 and could repurpose the thing for COVID and developed a paper-based testing kit called Feluda and got formal approval from DCGA.
More News
How strict parenting can impact children negatively | Lifestyle – Times of India Videos
Sonalee Kulkarni: Boundaries in the entertainment industry have been diminished | Marathi Movie News – Times of India
Sonalee Kulkarni: I am Punekar at heart | Marathi Movie News – Times of India